Clinical Trials

Groundbreaking initiative to beat aggressive form of leukemia
Only 27 percent of patients with acute myeloid leukemia live at least 5 years after the cancer is found. UT Southwestern Medical Center is working to change that, as one of only 11 sites in the U.S. selected for Beat AML, with a master clinical trial using a precision medicine approach to destroy the disease.

As part of one of the nation’s leading academic medical centers, UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center offers a broad spectrum of clinical trials aimed at improving the outcomes of patients with leukemia. Talk with your doctor if you’re interested in joining a clinical trial.

Some of our current clinical trials include:

Request an Appointment

To schedule a visit with a leukemia specialist at UT Southwestern's facilities in Dallas or to learn more about our services, request an appointment or call 214-645-8300.